Sinopharm Group Co. Ltd Net Asset Quality Index
Sinopharm Group Co. Ltd net asset quality index. Sinopharm Group Co. Ltd (X2S) has a Net Asset Quality Index of 34.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €390.36 Billion minus total liabilities of €256.20 Billion yields net assets of €134.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Sinopharm Group Co. Ltd net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sinopharm Group Co. Ltd (2013–2025)
Net asset quality index of Sinopharm Group Co. Ltd from 2013 to 2025. This chart shows how Sinopharm Group Co. Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 34.4%, representing net assets of €134.16 Billion against total assets of €390.36 Billion EUR. Check how strategically is Sinopharm Group Co. Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Sinopharm Group Co. Ltd Net Asset Quality Index by Year (2013–2025)
Sinopharm Group Co. Ltd net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Sinopharm Group Co. Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Sinopharm Group Co. Ltd (X2S) total market value.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.4% | €134.16 Billion | €390.36 Billion | €256.20 Billion | ▲ +2.1 pp |
| 2024 | 32.2% | €126.69 Billion | €392.83 Billion | €266.14 Billion | ▲ +0.9 pp |
| 2023 | 31.4% | €120.32 Billion | €383.39 Billion | €263.08 Billion | ▲ +1.2 pp |
| 2022 | 30.2% | €110.07 Billion | €364.78 Billion | €254.71 Billion | ▲ +0.5 pp |
| 2021 | 29.7% | €99.65 Billion | €335.41 Billion | €235.76 Billion | ▲ +0.8 pp |
| 2020 | 28.9% | €89.95 Billion | €311.24 Billion | €221.29 Billion | ▲ +0.4 pp |
| 2019 | 28.5% | €76.94 Billion | €269.89 Billion | €192.95 Billion | ▼ -0.5 pp |
| 2018 | 29.0% | €68.28 Billion | €235.77 Billion | €167.50 Billion | ▼ -1.3 pp |
| 2017 | 30.2% | €51.27 Billion | €169.54 Billion | €118.27 Billion | ▲ +2.0 pp |
| 2016 | 28.2% | €44.53 Billion | €157.71 Billion | €113.18 Billion | ▼ -1.1 pp |
| 2015 | 29.3% | €40.88 Billion | €139.43 Billion | €98.55 Billion | ▲ +1.1 pp |
| 2014 | 28.2% | €36.29 Billion | €128.66 Billion | €92.37 Billion | ▲ +1.1 pp |
| 2013 | 27.1% | €28.61 Billion | €105.45 Billion | €76.84 Billion | — |